Authors:
Ubeaud, G
Schiller, CD
Hurbin, F
Jaeck, D
Coassolo, P
Citation: G. Ubeaud et al., Comparison of the stability of some major cytochrome P450 and conjugation reactions in rat, dog and human hepatocyte monolayers, EUR J DRUG, 26(1-2), 2001, pp. 37-45
Authors:
Zuegge, J
Schneider, G
Coassolo, P
Lave, T
Citation: J. Zuegge et al., Prediction of hepatic metabolic clearance - Comparison and assessment of prediction models, CLIN PHARMA, 40(7), 2001, pp. 553-563
Authors:
Binda, D
Nicod, L
Viollon-Abadie, C
Rodriguez, S
Berthalot, A
Coassolo, P
Richert, L
Citation: D. Binda et al., Strain difference (WKY, SPRD) in the hepatic antioxidant status in rat andeffect of hypertension (SHR, DOCA). Ex vivo and in vitro data, MOL C BIOCH, 218(1-2), 2001, pp. 139-146
Authors:
Ubeaud, G
Schiller, CD
Hurbin, F
Jaeck, D
Coassolo, P
Citation: G. Ubeaud et al., Estimation of flavin-containing monooxygenase activity in intact hepatocyte monolayers of rat, hamster, rabbit, dog and human by using N-oxidation ofbenzydamine, EUR J PH SC, 8(4), 1999, pp. 255-260
Citation: T. Lave et al., Prediction of hepatic metabolic clearance based on interspecies allometricscaling techniques and in vitro in vivo correlations, CLIN PHARMA, 36(3), 1999, pp. 211-231
Authors:
Clozel, M
Ramuz, H
Clozel, JP
Breu, V
Hess, P
Loffler, BM
Coassolo, P
Roux, S
Citation: M. Clozel et al., Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use, J PHARM EXP, 290(2), 1999, pp. 840-846
Citation: G. Schneider et al., Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariatestatistical techniques, J MED CHEM, 42(25), 1999, pp. 5072-5076